Menu Search
Equities

Duearity AB

9DS:DEU

Duearity AB

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Duearity AB is a Sweden-based medical technology company. The Company's product is Tinearity G1. Tinearity G1 is a medical device that helps with tinnitus treatment. Tinearity G1 is based on Tinnitus Retraining Therapy, a white noise treatment that has been used clinically for several decades. Tinearity G1 consists of sound elements that lead white noise to the inner ear via the skull bone. The method is non-invasive and the ear canal is not affected.

  • Revenue in SEK (TTM)1.65m
  • Net income in SEK-26.19m
  • Incorporated2021
  • Employees6.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.